These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7928431)

  • 1. [Determination of prognosis-relevant factors in patients with hypo- or oropharyngeal carcinoma].
    Esser D; Meyer W; Willgeroth C; Motsch C
    HNO; 1994 Jul; 42(7):413-7. PubMed ID: 7928431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in carcinomas of the oropharynx and hypopharynx.
    Esser D; Theissig F; Willgeroth C
    Eur Arch Otorhinolaryngol; 1993; 250(3):154-6. PubMed ID: 8357605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma of the oropharynx and hypopharynx.
    Lin DT; Cohen SM; Coppit GL; Burkey BB
    Otolaryngol Clin North Am; 2005 Feb; 38(1):59-74, viii. PubMed ID: 15649499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and impact of lymph node metastases in oropharyngeal cancer.
    Shimizu K; Inoue H; Saitoh M; Ohtsuki N; Ishida H; Makino K; Amatsu M; Nibu K
    Acta Otolaryngol; 2006 Aug; 126(8):872-7. PubMed ID: 16846932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy.
    Chen SW; Yang SN; Liang JA; Lin FJ; Tsai MH
    Head Neck; 2009 Jun; 31(6):709-16. PubMed ID: 19260114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
    Doweck I; Robbins KT; Samant S; Vieira F
    World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx.
    Syms CA; Eibling DE; McCoy JP; Barnes L; Emanuel B; Fowler C; Wagner R; Johnson JT
    Laryngoscope; 1995 Feb; 105(2):149-55. PubMed ID: 8544594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional failure of hypopharyngeal squamous cell carcinoma].
    Oueslati Z; Zeglaoui I; Touati S; Gritli S; Mokni N; Nasr C; Boussen H; El-Benna F; Gamoudi A; El-May A; Ladgham A
    Cancer Radiother; 2004 Dec; 8(6):352-7. PubMed ID: 15619379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
    Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer of the oropharynx.
    Gluckman JL; Black RJ; Crissman JD
    Otolaryngol Clin North Am; 1985 Aug; 18(3):451-9. PubMed ID: 4047667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An attempt to evaluate prognosis in cases of metastasis from laryngeal and hypopharyngeal carcinoma to cervical lymph nodes].
    Sieczka JP
    Ann Acad Med Stetin; 1996; 42():157-76. PubMed ID: 9199119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial metastases in patients with squamous cell carcinoma of the head and neck.
    de Bree R; Mehta DM; Snow GB; Quak JJ
    Otolaryngol Head Neck Surg; 2001 Feb; 124(2):217-21. PubMed ID: 11226960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distant metastasis and incidence of second carcinomas in patients with oropharyngeal and hypopharyngeal carcinomas].
    Mohadjer C; Dietz A; Maier H; Weidauer H
    HNO; 1996 Mar; 44(3):134-9. PubMed ID: 8641899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival evaluation of treatment modality in squamous cell carcinoma of the oral cavity and oropharynx.
    Pericot J; Escribà JM; Valdés A; Biosca MJ; Monner A; Castellsagué X; Galiana R; Piulachs P; Escutia E; Mari A
    J Craniomaxillofac Surg; 2000 Feb; 28(1):49-55. PubMed ID: 10851674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy.
    Pedruzzi PA; Kowalski LP; Nishimoto IN; Oliveira BV; Tironi F; Ramos GH
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1196-204. PubMed ID: 19015451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interdisciplinary multi-modality therapy of advanced hypopharyngeal and proximal esophageal carcinomas].
    Fass J; Dreuw B; Korves B; von Saldern S; Andreopoulos B; Schumpelick V
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1502-4. PubMed ID: 9931925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.